MedTrace Logo

Modulus in XLIF Study

NCT04418817 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2025-12-22

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the safety and performance of the Modulus 3D-printed titanium interbody implant in patients undergoing thoracic and/or lumbar XLIF as measured by reported complications, radiographic outcomes, and patient-reported outcomes.

Conditions

  • Degenerative Disc Disease
  • Degenerative Spondylolisthesis
  • Degenerative Scoliosis

Sponsors & Collaborators

  • NuVasive

    lead INDUSTRY

Principal Investigators

  • Kyle Malone, MS · NuVasive

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-22
Primary Completion
2024-01-31
Completion
2024-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04418817 on ClinicalTrials.gov